209 related articles for article (PubMed ID: 19055172)
21. Solubilized benzoyl peroxide versus benzoyl peroxide/clindamycin in the treatment of moderate acne.
Tanghetti E; Kircik L; Wilson D; Dhawan S
J Drugs Dermatol; 2008 Jun; 7(6):534-8. PubMed ID: 18561583
[TBL] [Abstract][Full Text] [Related]
22. Combination therapy with adapalene-benzoyl peroxide and oral lymecycline in the treatment of moderate to severe acne vulgaris: a multicentre, randomized, double-blind controlled study.
Dréno B; Kaufmann R; Talarico S; Torres Lozada V; Rodríguez-Castellanos MA; Gómez-Flores M; De Maubeuge J; Berg M; Foley P; Sysa-Jedrzejowska A; Kerrouche N; Paliargues F; Bettoli V
Br J Dermatol; 2011 Aug; 165(2):383-90. PubMed ID: 21495995
[TBL] [Abstract][Full Text] [Related]
23. Improving treatment outcomes: tolerability of a fixed-combination clindamycin 1%-benzoyl peroxide 5% hydrating gel as monotherapy or in combination with a retinoid.
Eichenfield L
Cutis; 2009 Nov; 84(5 Suppl):12-7. PubMed ID: 19999188
[TBL] [Abstract][Full Text] [Related]
24. Clindamycin phosphate 1.2%- tretinoin 0.025% gel: vehicle characteristics, stability, and tolerability.
Del Rosso JQ; Jitpraphai W; Bhambri S; Momin S
Cutis; 2008 May; 81(5):405-8. PubMed ID: 18543590
[TBL] [Abstract][Full Text] [Related]
25. Tolerability and Efficacy of Clindamycin/Tretinoin versus Adapalene/Benzoyl Peroxide in the Treatment of Acne Vulgaris.
Aschoff R; Möller S; Haase R; Kuske M
J Drugs Dermatol; 2021 Mar; 20(3):295-301. PubMed ID: 33683070
[TBL] [Abstract][Full Text] [Related]
26. A multicentre, randomized, single-blind, parallel-group study comparing the efficacy and tolerability of benzoyl peroxide 3%/clindamycin 1% with azelaic acid 20% in the topical treatment of mild-to-moderate acne vulgaris.
Schaller M; Sebastian M; Ress C; Seidel D; Hennig M
J Eur Acad Dermatol Venereol; 2016 Jun; 30(6):966-73. PubMed ID: 26915831
[TBL] [Abstract][Full Text] [Related]
27. Randomized, observer-blind, split-face study to compare the irritation potential of 2 topical acne formulations over a 14-day treatment period.
Ting W
Cutis; 2012 Aug; 90(2):91-6. PubMed ID: 22988653
[TBL] [Abstract][Full Text] [Related]
28. [Azelaic acid 15% gel in the treatment of acne vulgaris. Combined results of two double-blind clinical comparative studies].
Gollnick HP; Graupe K; Zaumseil RP
J Dtsch Dermatol Ges; 2004 Oct; 2(10):841-7. PubMed ID: 16281587
[TBL] [Abstract][Full Text] [Related]
29. A phase IV, open-label study evaluating the use of triple-combination therapy with minocycline HCl extended-release tablets, a topical antibiotic/retinoid preparation and benzoyl peroxide in patients with moderate to severe acne vulgaris.
Zaenglein AL; Shamban A; Webster G; Del Rosso J; Dover JS; Swinyer L; Stein L; Lin X; Draelos Z; Gold M; Thiboutot D
J Drugs Dermatol; 2013 Jun; 12(6):619-25. PubMed ID: 23839176
[TBL] [Abstract][Full Text] [Related]
30. Optimizing topical combination therapy for the treatment of acne vulgaris.
Zeichner JA
J Drugs Dermatol; 2012 Mar; 11(3):313-7. PubMed ID: 22395581
[TBL] [Abstract][Full Text] [Related]
31. Efficacy and tolerability of fixed-combination acne treatment in adolescents.
Gold LS
Cutis; 2013 Mar; 91(3):152-9. PubMed ID: 23617089
[TBL] [Abstract][Full Text] [Related]
32. Clindamycin phosphate 1.2% / tretinoin 0.025%: a novel fixed-dose combination treatment for acne vulgaris.
Ochsendorf F
J Eur Acad Dermatol Venereol; 2015 Jun; 29 Suppl 5():8-13. PubMed ID: 26059820
[TBL] [Abstract][Full Text] [Related]
33. A current review of topical benzoyl peroxide: new perspectives on formulation and utilization.
Tanghetti EA; Popp KF
Dermatol Clin; 2009 Jan; 27(1):17-24. PubMed ID: 18984364
[TBL] [Abstract][Full Text] [Related]
34. Prospective, open-label, comparative study of clindamycin 1%/benzoyl peroxide 5% gel with adapalene 0.1% gel in Asian acne patients: efficacy and tolerability.
Ko HC; Song M; Seo SH; Oh CK; Kwon KS; Kim MB
J Eur Acad Dermatol Venereol; 2009 Mar; 23(3):245-50. PubMed ID: 19438817
[TBL] [Abstract][Full Text] [Related]
35. Tolerability and irritation potential of four topical acne regimens in healthy subjects.
Grove G; Zerweck C; Gwazdauskas J
J Drugs Dermatol; 2013 Jun; 12(6):644-9. PubMed ID: 23839180
[TBL] [Abstract][Full Text] [Related]
36. Advancement in benzoyl peroxide-based acne treatment: methods to increase both efficacy and tolerability.
Fakhouri T; Yentzer BA; Feldman SR
J Drugs Dermatol; 2009 Jul; 8(7):657-61. PubMed ID: 19588642
[TBL] [Abstract][Full Text] [Related]
37. Comparing a novel solubilized benzoyl peroxide gel with benzoyl peroxide/clindamycin: final data from a multicenter, investigator-blind, randomized study.
Kircik L; Green L; Thiboutot D; Tanghetti E; Wilson D; Dhawan S; Parr L
J Drugs Dermatol; 2009 Sep; 8(9):812-8. PubMed ID: 19746673
[TBL] [Abstract][Full Text] [Related]
38. Adapalene-benzoyl peroxide once-daily, fixed-dose combination gel for the treatment of acne vulgaris: a randomized, bilateral (split-face), dose-assessment study of cutaneous tolerability in healthy participants.
Andres P; Pernin C; Poncet M
Cutis; 2008 Mar; 81(3):278-84. PubMed ID: 18441854
[TBL] [Abstract][Full Text] [Related]
39. Comparison of clindamycin/benzoyl peroxide, tretinoin plus clindamycin, and the combination of clindamycin/benzoyl peroxide and tretinoin plus clindamycin in the treatment of acne vulgaris: a randomized, blinded study.
Bowman S; Gold M; Nasir A; Vamvakias G
J Drugs Dermatol; 2005; 4(5):611-8. PubMed ID: 16167420
[TBL] [Abstract][Full Text] [Related]
40. A multicentre, randomized, single-blind comparison of topical clindamycin 1%/benzoyl peroxide 5% once-daily gel versus clindamycin 1% twice-daily gel in the treatment of mild to moderate acne vulgaris in Chinese patients.
Xu JH; Lu QJ; Huang JH; Hao F; Sun QN; Fang H; Gu J; Dong XQ; Zheng J; Luo D; Li FQ; Wang G; Gu H; Tian HQ; Yang HL; Xi LY; Li M; Zheng M; Wu Y; Tu YT; He YL; Zhao G; Sheng WX; Li J; Hamedani AG
J Eur Acad Dermatol Venereol; 2016 Jul; 30(7):1176-82. PubMed ID: 27075705
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
